The FDA has approved Wegovy (semaglutide) tablets, the first oral GLP-1 receptor agonist for the treatment of obesity.

On Monday evening, the Food and Drug Administration approved Novo Nordisk’s high-dose oral formulation of semaglutide for ...

The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

Talk about semaglutide—the drug better known by brand names like Ozempic, Wegovy, and Rybelsus—is everywhere these days. But if you’re considering getting pregnant or want to use the med ...

Switching From Tirzepatide to semaglutide for weight loss? This article was reviewed by Lynn Marie Morski, MD, JD. Key takeaways: You can switch from tirzepatide to ...

Semaglutide can help the body make more insulin and improves insulin sensitivity, which in turn lowers blood-glucose levels ...

Responding to a query on the impact on pricing with the generics’ entry, he said, “The market will be competitive and evolve ...

Key market opportunities for liraglutide and semaglutide include their growing role in diabetes and obesity treatment due to ...